Articles by master

Saiba Animal Health AG’s executes a license for the development and commercialization of a lead product candidate.

Pfäffikon (SZ) Switzerland 21st of December 2022: Saiba Animal Health AG announced today the achievement of a significant collaboration milestone stemming from a partnership agreement initiated in October 2019. The partner, a leading global animal health company, exercised their option to take an exclusive license for the commercialization and development of one of Saiba’s product …

Read More

Saiba Animal Health AG Signs Second Agreement with Boehringer Ingelheim

Pfäffikon (SZ) Switzerland 1st of February 2022: Saiba Animal Health AG announced the commencement of another collaboration with Boehringer Ingelheim, a global leader in animal health. The new partnership further enhances one of Saiba’s key business goals, which is to advance its technology and product candidates through strategic alliances with top-tier companies. Towards this end, …

Read More

Saiba Animal Health AG signs a deal to test and develop another product candidate from its pipeline

Päffikon (SZ) Switzerland 16th of July 2021 – Saiba Animal Health AG reported today that it has entered into its fifth agreement with a leading Animal Health Company Saiba Animal Health AG announced today the commencement of another collaboration with a major animal health company. The execution of this new agreement brings to five the …

Read More

Saiba Animal Health AG has a new development partner for its two lead projects

Päffikon (SZ) Switzerland 19th of April 2021: Saiba Animal Health reported today that the rights for its two lead assets, SAH001 (HypoCat) and SAH003 (CAD vaccine) have been transferred from Benchmark Animal Health to a leading global Animal Health Company. In 2014 and in 2015, Saiba Animal Heath (HypoPet AG) and Benchmark Holdings PLC entered …

Read More

Saiba Animal Health AG enters into an Agreement with Boehringer Ingelheim

Pfäffikon (SZ) Switzerland 9th of December 2020 – Saiba Animal Health reported today that it has executed a contract with Boehringer Ingelheim. Saiba Animal Health AG announced Wednesday the commencement of an agreement with Boehringer Ingelheim, a global leader in animal health. The new partnership will further enable a core element of Saiba’s business strategy, …

Read More

Saiba Animal Health led consortium receives top ranking and funding from Eurostars Program for the research and development of a vaccine for African Swine Fever.

Zürich Switzerland 2nd of June 2020 – Saiba Animal Health AG today announced the ASF-INNOVAC consortium in which it is the lead SME was ranked 1st among 378 funding applications and will thus receive funding for 3 years to research and develop a vaccine against the African Swine Fever; one of the most serious infectious …

Read More
1 2 3